Zobrazeno 1 - 10
of 45
pro vyhledávání: '"TOSHIHIRO OTSUKA"'
Autor:
Atsushi Fukunaga, Yasumasa Kakei, Sae Murakami, Yuji Kan, Koji Masuda, Masatoshi Jinnin, Ken Washio, Hiroo Amano, Tohru Nagano, Akihisa Yamamoto, Toshihiro Otsuka, Shunsuke Takahagi, Motoi Takenaka, Naoko Ishiguro, Koremasa Hayama, Naoko Inomata, Yukinobu Nakagawa, Akiko Sugiyama, Michihiro Hide
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundFor treating patients with refractory chronic spontaneous urticaria (CSU) resistant to standard doses of 2nd generation H1-antihistamines (H1AH) the International and Japanese guidelines recommend increasing H1AH dose. The latter also recom
Externí odkaz:
https://doaj.org/article/bd24e6bf28374599bec1ab1ebacc63e9
Autor:
Yusuke Matsuzaka, Manabu Noguchi, Shigeki Kanamura, Kengo Maeda, Takahiro Hisano, Daizo Tanaka, Yukihiro Ando, Tomokazu Yamamoto, Yoshiro Morimoto, Hiroki Ozawa, Toshihiro Otsuka
Publikováno v:
Neurocase. 28:310-313
In the treatment of schizophrenia, long-term pharmacotherapy with D2-receptor antagonists can induce dopamine supersensitivity psychosis (DSP). We report a male patient with schizophrenia with suspected DSP due to excessive polypharmacy. He was hospi
Autor:
SHINGO MIYAMOTO, TOYOFUMI HIRAKAWA, YUKIKO NOGUCHI, DAICHI URUSHIYAMA, KOHEI MIYATA, TSUKASA BABA, FUSANORI YOTSUMOTO, SHIN'ICHIRO YASUNAGA, KAZUHIKO NAKABAYASHI, KENICHIRO HATA, WATARU NAKAGAWA, TOSHIHIRO OTSUKA, YOSHIKO NOZAWA, IPPEI FURUHATA, JITSUO MIKASA
Publikováno v:
In Vivo; Nov/Dec2023, Vol. 37 Issue 6, p2555-2563, 9p
Autor:
Toshihiro Otsuka, Junichiro Kumai
Publikováno v:
Japanese Journal of Stroke. 44:324-328
Publikováno v:
Japanese Journal of Stroke.
Publikováno v:
An Official Journal of the Japan Primary Care Association. 45:90-92
Publikováno v:
Journal of Environmental Engineering (Transactions of AIJ). 85:913-921
Autor:
Hideaki Tanizaki, Shinichi Moriwaki, Atsushi Fukunaga, Chikako Nishigori, Yoshiko Oda, Toshihiro Otsuka, Aoi Yamasaki
Publikováno v:
Journal of Cutaneous Immunology and Allergy. 2(1):31-34
Omalizumab, a humanized anti-IgE monoclonal antibody, has been approved in Japan for the treatment of antihistamine-resistant idiopathic chronic spontaneous urticaria. We herein report a 27-year-old Japanese woman suffering from a 2-year history of s
Autor:
Hiroaki Neki, Fumitaka Yamane, Eisuke Tsukagoshi, Toshihiro Otsuka, Shinya Kohyama, Satomi Mizuhashi, Azusa Yonezawa
Publikováno v:
Journal of Neuroendovascular Therapy. 13:430-434
Autor:
Hiroaki Neki, Shinya Kohyama, Shoichiro Ishihara, Toshihiro Otsuka, Hideaki Ishihara, Fumitaka Yamane, Azusa Yonezawa
Publikováno v:
Journal of Neuroendovascular Therapy. 12:273-280